Skip to content

Clinical trials

Completed Phase 2 Lysosomal Storage Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lysosomal Storage Diseases Phase: Phase 2 Status: Completed Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20112
20142
20151
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.2
BioMarin Pharmaceutical1
Orchard Therapeutics1
Shire1
The Hospital for Sick Children1
Ultragenyx Pharmaceutical Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lysosomal Storage Diseases7
Cholesterol Ester Storage Disease2
Metabolic Diseases2
Wolman Disease2
Gangliosidoses, GM21
Genetic Diseases, Inborn1
Infant, Newborn, Diseases1
Leukodystrophy, Metachromatic1
Lipid Metabolism Disorders1
Lipid Metabolism, Inborn Errors1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.